ABSTRACT
This chapter focuses on one particular source that has provided key concepts for the EU regulation on health claims: an industry-funded think tank and its consortium of life scientists: the European branch of the International Life Sciences Institute (ILSI). It details the problems and debates between industry and EFSA after the implementation of the regulation elsewhere. The chapter argues that, on the border between food and drugs, 'science' is rhetorically mobilized to refer to particular concepts and technologies of demonstration It consists of a discussion of ILSI's main nutritional concepts presented in the FUFOSE Consensus Document. Functional food science is designed to craft a territory for therapeutic claims outside the scientific and regulatory regime of pharmaceuticals, but it actually has a lot in common with 'rational pharmacology' or 'drug design' The chapter shows how ILSI engages in defining health differently and imagining the body differently than in clinical trials for drug testing.
